Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cns Pharmaceuticals Inc (CNSP)

Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 227
  • Shares Outstanding, K 1,443
  • Annual Sales, $ 0 K
  • Annual Income, $ -18,850 K
  • 60-Month Beta 2.62
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade CNSP with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -128.72
  • Most Recent Earnings $-6.72 on 08/14/24
  • Next Earnings Date 08/12/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.30
  • Growth Rate Est. (year over year) +333,100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0955 +64.61%
on 08/16/24
0.5348 -70.61%
on 07/31/24
-0.2528 (-61.66%)
since 07/30/24
3-Month
0.0955 +64.61%
on 08/16/24
10.8800 -98.56%
on 05/31/24
-10.7228 (-98.56%)
since 05/30/24
52-Week
0.0955 +64.61%
on 08/16/24
137.5000 -99.89%
on 11/20/23
-87.3428 (-99.82%)
since 08/29/23

Most Recent Stories

More News
CNS Pharmaceuticals (NASDAQ: CNSP) CEO to Present at Virtual Biotech Investment Webinar

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company...

CNSP : 0.1572 (+6.94%)
CNS Pharmaceuticals (NASDAQ: CNSP) CEO to be Featured in Virtual Investor CEO Connect Segment

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be spotlighted...

CNSP : 0.1572 (+6.94%)
CNS Pharmaceuticals (NASDAQ: CNSP) Publishes Q2 2024 Results

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today released...

CNSP : 0.1572 (+6.94%)
CNS Pharmaceuticals (NASDAQ: CNSP) Inks Exclusive License in ‘Transformational’ Step to Treating GBM

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered...

CNSP : 0.1572 (+6.94%)
CNS Pharmaceuticals (NASDAQ: CNSP) to Present at SNO/ASCO CNS Cancer Conference

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be participating...

CNSP : 0.1572 (+6.94%)
CNS Pharmaceuticals (NASDAQ: CNSP) Exec to Present at Virtual Investor Closing Bell Series

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, will be featured...

CNSP : 0.1572 (+6.94%)
CNS Pharmaceuticals (NASDAQ: CNSP) Enters Securities Purchase Agreements Worth Estimated $1.98M

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered...

CNSP : 0.1572 (+6.94%)
CNS Pharmaceuticals (NASDAQ: CNSP) Announces Pricing of Registered Direct, Concurrent Private Placement

CNS Pharmaceuticals (NASDAQ: CNSP) is a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system. The company...

CNSP : 0.1572 (+6.94%)
CNS Pharmaceuticals(NASDAQ: CNSP) Enters in Purchase Agreements, Announces Pricing

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, has entered...

CNSP : 0.1572 (+6.94%)
CNS Pharmaceuticals (NASDAQ: CNSP) Announces Reverse Stock Split

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, today announced...

CNSP : 0.1572 (+6.94%)

Business Summary

CNS Pharmaceuticals Inc. is a pre-clinical stage biotechnology company specializing in the development of novel treatments for brain tumors. The company's lead drug includes Berubicin, for the treatment of Glioblastoma Multiforme and potentially for other CNS malignancies. CNS Pharmaceuticals Inc. is...

See More

Key Turning Points

3rd Resistance Point 0.2003
2nd Resistance Point 0.1836
1st Resistance Point 0.1704
Last Price 0.1572
1st Support Level 0.1405
2nd Support Level 0.1238
3rd Support Level 0.1106

See More

52-Week High 137.5000
Fibonacci 61.8% 85.0115
Fibonacci 50% 68.7978
Fibonacci 38.2% 52.5840
Last Price 0.1572
52-Week Low 0.0955

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar